These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6502313)

  • 1. Decreased response of plasma immunoreactive erythropoietin to "available oxygen" in anemia of prematurity.
    Brown MS; Garcia JF; Phibbs RH; Dallman PR
    J Pediatr; 1984 Nov; 105(5):793-8. PubMed ID: 6502313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anemia of prematurity: determinants of the erythropoietin response.
    Stockman JA; Graeber JE; Clark DA; McClellan K; Garcia JF; Kavey RE
    J Pediatr; 1984 Nov; 105(5):786-92. PubMed ID: 6502312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human erythropoietin in the treatment of anemia of prematurity.
    Chen JY; Wu TS; Chanlai SP
    Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating erythroid progenitors in the anemia of prematurity.
    Shannon KM; Naylor GS; Torkildson JC; Clemons GK; Schaffner V; Goldman SL; Lewis K; Bryant P; Phibbs R
    N Engl J Med; 1987 Sep; 317(12):728-33. PubMed ID: 3627181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity.
    Ohls RK; Christensen RD
    J Pediatr; 1991 Nov; 119(5):781-8. PubMed ID: 1941387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postnatal changes in erythropoietin levels in untransfused premature infants.
    Brown MS; Phibbs RH; Garcia JF; Dallman PR
    J Pediatr; 1983 Oct; 103(4):612-7. PubMed ID: 6194281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma erythropoietin concentrations during the early anemia of prematurity.
    Hågå P; Meberg A; Halvorsen S
    Acta Paediatr Scand; 1983 Nov; 72(6):827-31. PubMed ID: 6673483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anemia of prematurity. Factors governing the erythropoietin response.
    Stockman JA; Garcia JF; Oski FA
    N Engl J Med; 1977 Mar; 296(12):647-50. PubMed ID: 851485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
    Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
    Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia of prematurity. Current concepts in the issue of when to transfuse.
    Stockman JA
    Pediatr Clin North Am; 1986 Feb; 33(1):111-28. PubMed ID: 3513096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current controversies in the management of the anemia of prematurity.
    Bishara N; Ohls RK
    Semin Perinatol; 2009 Feb; 33(1):29-34. PubMed ID: 19167579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin and the anemia of prematurity.
    Dallman PR
    J Pediatr; 1984 Nov; 105(5):756-7. PubMed ID: 6502305
    [No Abstract]   [Full Text] [Related]  

  • 13. Vascular endothelial growth factor as marker for tissue hypoxia and transfusion need in anemic infants: a prospective clinical study.
    Tschirch E; Weber B; Koehne P; Guthmann F; von Gise A; Wauer RR; Rüdiger M
    Pediatrics; 2009 Mar; 123(3):784-90. PubMed ID: 19255003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the need for transfusion of premature infants and role of hematocrit, clinical signs, and erythropoietin level.
    Keyes WG; Donohue PK; Spivak JL; Jones MD; Oski FA
    Pediatrics; 1989 Sep; 84(3):412-7. PubMed ID: 2771544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum erythropoietin concentrations in symptomatic infants during the anaemia of prematurity.
    Meyer J; Sive A; Jacobs P
    Arch Dis Child; 1992 Jul; 67(7 Spec No):818-21. PubMed ID: 1519982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between two and five doses a week of recombinant human erythropoietin for anemia of prematurity: a randomized trial.
    Brown MS; Keith JF
    Pediatrics; 1999 Aug; 104(2 Pt 1):210-5. PubMed ID: 10428996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial, erythropoietic, and metabolic adaptations to anemia of prematurity.
    Lachance C; Chessex P; Fouron JC; Widness JA; Bard H
    J Pediatr; 1994 Aug; 125(2):278-82. PubMed ID: 8040778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity.
    Soubasi V; Kremenopoulos G; Diamanti E; Tsantali C; Sarafidis K; Tsakiris D
    J Pediatr; 1995 Aug; 127(2):291-7. PubMed ID: 7636658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.
    Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G
    N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early treatment of premature infants with recombinant human erythropoietin.
    Messer J; Haddad J; Donato L; Astruc D; Matis J
    Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.